Novartis AG

(NYSE:NVS)

Latest On Novartis AG (NVS):

Date/Time Type Description Signal Details
2024-03-07 04:57 ESTDividendA dividend of $3.78 has been announced on Feb 12, 2024. It will be paid Nov 30, -0001 with an ex-dividend date of Mar 7, 2024.Neutral
2023-05-27 22:22 ESTNewsWhy 2023 is turning into the year of the healthcare spinoffN/A
2023-05-26 18:42 ESTNewsEMA recommends revoking approval of Novartis' sickle cell disease drug Adakveo in EUN/A
2023-05-25 14:01 ESTNewsNovartis' Sandoz gets EMA review for biosimilar to Amgen's Prolia, XgevaN/A
2023-05-22 14:42 ESTNewsAvrobio up 69% on plans to sell gene therapy program to NovartisN/A
2023-05-15 16:58 ESTNewsNovartis appoints 10-member board for Sandoz unit ahead of spinoffN/A
2023-05-10 09:08 ESTNewsNovartis' Sandoz to use Evotec's technology in pact to develop biosimilarsN/A
2023-05-04 05:49 ESTNewsNovartis' Sandoz inks pact to exclusively sell 6 products in USN/A
2023-05-03 17:23 ESTNewsImmix stock slumps ~20% amid interim data for IMX-110 in colorectal cancerN/A
2023-04-27 12:03 ESTNewsNovartis Cosentyx gets EMA panel backing to treat painful skin disorderN/A
2023-04-26 23:42 ESTNewsNovartis: Valuation Seems FairN/A
2023-04-26 11:33 ESTNewsBristol Myers to acquire viral vector manufacturing site in Illinois from NovartisN/A
2023-04-26 11:33 ESTNewsNovartis' iptacopan improves hemoglobin levels in rare blood disorder trial full dataN/A
2023-04-25 23:21 ESTNewsHot Stocks: Earnings sparked movement in PEP, JBLU, NVS, MCD, BIIB and HALN/A
2023-04-25 11:18 ESTNewsNovartis beats Q1 top and bottom line estimates; raises FY23 outlook & planned spin-off on track for H2N/A
2023-04-25 11:18 ESTNewsNovartis trades higher as Entresto, new drugs drive Q1 revenue, raises FY23 outlookN/A
2023-04-25 11:18 ESTNewsNovartis AG 2023 Q1 - Results - Earnings Call PresentationN/A
2023-04-25 11:18 ESTNewsNovartis: Limited Upside Despite Strong First Quarter Results, Improved GuidanceN/A
2023-04-25 11:17 ESTNewsNovartis AG (NVS) Q1 2023 Earnings Call TranscriptN/A
2023-04-24 23:47 ESTNewsNovartis hits 52-week high as Wall Street awaits Q1 2023 earningsN/A
2023-04-20 15:27 ESTNewsNovartis Kesimpta shows benefit in multiple sclerosis patients in 5-year dataN/A
2023-04-20 15:26 ESTNewsNovartis, BeiGene tislelizumab meets main goal in gastric/esophagus cancer trialN/A
2023-04-19 16:50 ESTNewsAmgen wins appeals court ruling in patent dispute over psoriasis drug OtezlaN/A
2023-04-04 05:38 ESTNewsNovartis Humira biosimilar's high concentration gets approval in EUN/A
2023-03-31 12:40 ESTNewsNovartis' heart drug Entresto gets EMA nod for expanded use in childrenN/A
2023-03-28 14:10 ESTNewsBicycle stock pops on cancer drug discovery pact with Novartis, gets $50M upfrontN/A
2023-03-27 22:52 ESTNewsHot Stocks: ROKU and PINS rises on analyst upgrade; CAT stock and FYBR falls on downgrade; NVS higher on cancer trial successN/A
2023-03-27 22:52 ESTNewsNovartis upgraded to hold at Deutsche Bank following breast cancer drug resultsN/A
2023-03-27 22:51 ESTNewsWhy did Novartis stock go up today? Early breast cancer trial resultsN/A
2023-03-27 07:22 ESTNewsNovartis stock jumps on cancer trial successN/A
2023-03-22 19:34 ESTNewsNovartis Humira biosimilar's high concentration gets FDA approvalN/A
2023-03-22 19:34 ESTNewsNovartis to not go ahead with UK trial of cholesterol therapy Leqvio - reportN/A
2023-03-18 07:31 ESTNewsSangamo down post-market as Novartis, Biogen end collaborationsN/A
2023-03-17 16:30 ESTNewsNovartis Tafinlar Mekinist combo gets FDA approval to treat brain cancer in childrenN/A
2023-03-14 12:27 ESTNewsNovartis begins sale of certain eye care assets - reportN/A
2023-03-13 05:53 ESTNewsNovartis launches CHF10B stock buyback programN/A
2023-03-10 15:52 ESTNewsNovartis' Sandoz to invest $400M to build biosimilar production plant in SloveniaN/A
2023-03-09 04:56 ESTDividendA dividend of $3.47 has been announced on Feb 2, 2023. It will be paid Mar 20, 2023 with an ex-dividend date of Mar 9, 2023.Neutral
2023-03-06 21:20 ESTNewsVoyager stock pops on getting $25M from Novartis under license dealN/A
2023-03-06 21:19 ESTNewsNovartis: Cautiously Optimistic, HoldN/A
2023-03-03 14:06 ESTNewsNovartis files for FDA approval of radioligand facility to ramp up production of PluvictoN/A
2023-02-25 00:14 ESTNewsNovartis ends NASH collaboration with PliantN/A
2023-02-23 21:35 ESTNewsIntellia, Novartis end gene editing partnership for sickle cell diseaseN/A
2023-02-20 15:29 ESTNewsNovartis appoints perfume company Firmenich CEO as chairman-designate of SandozN/A
2023-02-09 03:55 ESTNewsNovartis CEO to lead top U.S. pharma lobbyN/A
2023-02-08 14:42 ESTNewsNovartis, Bayer commit financial aid to quake hit Turkey, Syria as rescue operations continueN/A
2023-02-07 12:29 ESTNewsNovartis' biosimilar of Amgen's bone disorder drugs Prolia, Xgeva gets FDA reviewN/A
2023-02-03 01:25 ESTNewsNovartis drops plans to develop Huntington’s disease candidateN/A
2023-02-01 23:01 ESTNewsNovartis ends plans to develop Cosentyx for another autoimmune conditionN/A
2023-02-01 10:00 ESTNewsNovartis reports mixed Q4 earnings, continue to grow with further core margin expansion; initiates FY23 guidanceN/A

About Novartis AG (NVS):

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, established, and cardiovascular, renal and metabolism medicine products. The Sandoz segment provides active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a range of therapeutic areas, as well as finished dosage form anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and an agreement with CureVac to manufacture COVID-19 vaccine candidate CVnCoV. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

NVS Quotes by TradingView

See Advanced Chart

General

  • Name Novartis AG
  • Symbol NVS
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-General
  • Full Time Employees 105,794
  • Last Split Factor1116:1000
  • Last Split Date2019-04-09
  • Fiscal Year EndDecember
  • IPO Date1991-11-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.novartis.com
View More

Valuation

  • Trailing PE 24.24
  • Forward PE 13.44
  • Price/Sales (Trailing 12 Mt.) 3.9
  • Price/Book (Most Recent Quarter) 3.38
  • Enterprise Value Revenue 4.35
  • Enterprise Value EBITDA 12.6
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $6.37
  • Next Year EPS Estimate $6.79
  • Next Quarter EPS Estimate $1.58
  • Profit Margin 16%
  • Operating Margin 24%
  • Return on Assets 6%
  • Return on Equity 14%
  • Revenue 49.76 billion
  • Earnings Per Share $3.52
  • Revenue Per Share $21.85
  • Gross Profit 35.36 billion
  • Quarterly Earnings Growth 1.9%
View More

Highlights

  • Market Capitalization 192.55 billion
  • EBITDA 17.27 billion
  • PE Ratio 13.65
  • PEG Ratio 2.19
  • Analyst Target Price $104.67
  • Book Value Per Share $25.08
View More

Share Statistics

  • Shares Outstanding 2.26 billion
  • Shares Float 2.11 billion
  • % Held by Insiders <1%
  • % Held by Institutions 10.08%
  • Shares Short 6.7 million
  • Shares Short Prior Month 5.35 million
  • Short Ratio 2.94
View More

Technicals

  • Beta 0.48
  • 52 Week High $94.72
  • 52 Week Low $67.52
  • 50 Day Moving Average 88.18
  • 200 Day Moving Average 88.65
View More

Dividends

  • Forward Annual Dividend Rate $3.2
  • Forward Annual Dividend Yield 3.74%
  • Payout Ratio 58%
  • Dividend Date 2021-03-15
  • ExDividend Date 2021-03-04
  • Dividend Per Share $3.4
  • Dividend Yield 4.04%
View More

Novartis AG (NVS) Dividend Calendar:

Novartis AG pays an annual dividend of $3.2 per share, with a dividend yield of 4.04%.
NVS's last dividend payment was made to shareholders on March 15, 2021.
Novartis AG pays out 58% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Novartis AG (NVS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-01-26$13.03 billion$1.34$1.39-3.81%
2020-09-302020-10-27$12.54 billion$1.52$1.454.88%
2020-06-302020-07-21$11.62 billion$1.36$1.332.07%
2020-03-312020-04-28$12.71 billion$1.56$1.3615.02%
2019-12-312020-01-29$12.72 billion$1.32$1.311.01%
2019-09-302019-10-22$12.48 billion$1.41$1.354.61%
2019-06-302019-07-18$12.02 billion$1.34$1.248.5%
2019-03-312019-04-24$11.46 billion$1.21$1.21-0.17%
2018-12-312019-01-30$13.66 billion$1.25$1.30-3.48%
2018-09-302018-10-18$13.12 billion$1.32$1.34-1.78%
2018-06-302018-07-18$13.45 billion$1.29$1.281.08%
2018-03-312018-04-19$12.69 billion$1.28$1.270.79%
2017-12-312018-01-24$12.92 billion$1.21$1.173.84%
2017-09-302017-10-24$12.41 billion$1.29$1.243.81%
2017-06-302017-07-18$12.24 billion$1.22$1.174.59%
2017-03-312017-04-25$11.54 billion$1.13$1.102.28%
2016-12-312017-01-25$12.32 billion$1.12$1.101.42%
2016-09-302016-10-25$12.13 billion$1.23$1.193.28%
2016-06-302016-07-19$12.47 billion$1.23$1.175.2%
2016-03-312016-04-21$11.6 billion$1.17$1.161.22%
2015-12-312016-01-27$12.52 billion$1.12$1.18-5.45%
2015-09-302015-10-27$12.27 billion$1.27$1.31-3.05%
2015-06-302015-07-21$12.69 billion$1.25$1.240.81%
2015-03-312015-04-23$11.96 billion$1.29$1.1017.27%
2014-12-312015-01-27$13.13 billion$1.21$1.210%
2014-09-302014-10-28$13.05 billion$1.37$1.296.2%
2014-06-302014-07-17$13.41 billion$1.34$1.40-4.29%
2014-03-312014-04-24$12.83 billion$1.28$1.33-3.76%
2013-12-312014-01-29$13.44 billion$1.19$1.26-5.56%
2013-09-302013-10-22$12.75 billion$1.25$1.31-4.58%
2013-06-302013-07-17$13.13 billion$1.28$1.29-0.78%
2013-03-312013-04-24$12.77 billion$1.32$1.283.13%
2012-12-312013-01-23$14.83 billion$1.27$1.196.72%
2012-09-302012-10-25$13.81 billion$1.34$1.36-1.47%
2012-06-302012-07-19$14.3 billion$1.38$1.296.98%
2012-03-312012-04-24$13.74 billion$1.27$1.32-3.79%
2011-12-312012-01-25$14.78 billion$1.23$1.202.5%
2011-09-302011-10-25$14.84 billion$1.45$1.51-3.97%
2011-06-302011-07-19$14.92 billion$1.48$1.405.71%
2011-03-312011-04-19$14.03 billion$1.41$1.317.63%
2010-12-312011-01-27$14.2 billion$1.14$1.25-8.8%
2010-09-302010-10-21$12.58 billion$1.27$1.205.83%
2010-06-302010-07-15$11.72 billion$1.20$1.136.19%
2010-03-312010-04-20$12.13 billion$1.44$1.2317.07%
2009-12-312010-01-26$12.93 billion$1.01$1.10-8.18%
2009-09-302009-10-22$11.09 billion$0.92$0.95-3.16%
2009-06-302009-07-16$10.55 billion$0.89$0.854.71%
2009-03-312009-04-23$9.71 billion$0.87$0.870%
2008-12-312009-01-28$10.08 billion$0.66$0.79-16.46%
2008-09-302008-10-20$10.75 billion$0.92$0.95-3.16%
2008-06-302008-07-17$10.73 billion$0.98$0.935.38%
2008-03-312008-04-21$9.91 billion$1.02$0.8914.61%
2007-12-312008-01-17$9.93 billion$0.40$0.73-45.21%
2007-09-302007-10-18$9.61 billion$0.68$0.76-10.53%
2007-06-302007-07-17$9.4 billion$0.83$0.786.41%
2007-03-312007-04-23$9.13 billion$0.92$0.849.52%
2006-12-312007-01-18$9.4 billion$0.70$0.78-10.26%
2006-09-302006-10-19$8.82 billion$0.79$0.763.95%
2006-06-302006-07-17$8.51 billion$0.73$0.79-7.59%
2006-03-312006-04-24$7.67 billion$0.83$0.7116.9%
2005-12-312006-01-19$7.45 billion$0.58$0.71-18.31%
2005-09-302005-10-18$8.42 billion$0.71$0.72-1.39%
2005-06-302005-07-14$7.8 billion$0.70$0.666.06%
2005-03-312005-04-21$7.34 billion$0.64
2004-12-312005-01-20$7.58 billion$0.56$0.60-6.67%
2004-09-302004-10-21$7.06 billion$0.63$0.588.62%
2004-06-302004-07-20$6.97 billion$0.63$0.596.78%
2004-03-312004-04-22$6.64 billion$0.52$0.53-1.89%
2003-12-312004-01-22$6.73 billion$0.55$0.533.77%
2003-09-302003-10-20$6.21 billion$0.52$0.520%
2003-06-302003-07-21$6.2 billion$0.52$0.511.96%
2003-03-312003-04-15$5.72 billion$0.43$0.46-6.52%
2002-12-312003-01-23$7 billion$0.46$0.51-9.86%
2002-09-302002-10-17$5.54 billion$0.47$0.447.11%
2002-06-302002-06-30$6.16 billion$0.50
2002-03-312002-03-31$4.74 billion$0.41
1997-06-301997-09-02$0.79$0.790%
1997-03-311997-04-22$0.52$0.4515.56%

Novartis AG (NVS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Novartis AG (NVS) Chart:

Novartis AG (NVS) News:

Below you will find a list of latest news for Novartis AG (NVS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Novartis AG (NVS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-17550CALL0 0119.38TRUE00
2024-05-17600CALL0 0105.1TRUE00
2024-05-17650CALL0 089.2TRUE00
2024-05-17700CALL0 076.1TRUE00
2024-05-17750CALL0 065.91TRUE00
2024-05-17800CALL0 054.53TRUE00
2024-05-178510.41CALL0 150.14TRUE00
2024-05-1787.58.21CALL0 2036.25TRUE00
2024-05-17905.75CALL686 333.15TRUE5.750
2024-05-1792.53.8CALL454 200529.06TRUE1.220.47
2024-05-17952.55CALL523 210829.16FALSE1.050.7
2024-05-1797.51.56CALL1654 1174728.55FALSE0.760.95
2024-05-171001CALL37 124529.53FALSE0.551.22
2024-05-171050.55CALL3336 33334.45FALSE0.550
2024-05-171100.3CALL3 038.07FALSE0.30
2024-05-171150CALL0 00FALSE00
2024-05-171200CALL0 00FALSE00
2024-05-171250CALL0 00FALSE00
2024-05-171300.05CALL505 050.89FALSE0.050
2024-05-171350.05CALL200 055.92FALSE0.050
2024-05-171400CALL0 00FALSE00
2024-05-171450CALL0 00FALSE00
2024-05-17550.05PUT50 083.62FALSE0.050
2024-05-17600.05PUT500 071.24FALSE0.050
2024-05-17650.05PUT2 059.74FALSE0.050
2024-05-17700PUT0 00FALSE00
2024-05-17750.13PUT0 10FALSE00
2024-05-17800.25PUT0 236.06FALSE00
2024-05-17850.28PUT1 10327.73FALSE0.280
2024-05-1787.50.48PUT4 3925.45FALSE0.480
2024-05-17900.9PUT25 57922.49FALSE-0.25-0.22
2024-05-1792.51.66PUT75 68821.94FALSE-0.49-0.23
2024-05-17952.85PUT54 50322.96TRUE-0.65-0.19
2024-05-1797.54.42PUT2 10922.27TRUE-1.08-0.2
2024-05-171007.2PUT0 1222.21TRUE00
2024-05-1710510.3PUT0 235.27TRUE00
2024-05-171100PUT0 061.83TRUE00
2024-05-171150PUT0 075.41TRUE00
2024-05-171200PUT0 085.32TRUE00
2024-05-171250PUT0 059.22TRUE00
2024-05-171300PUT0 0103.06TRUE00
2024-05-171350PUT0 0111.11TRUE00
2024-05-171400PUT0 0116.94TRUE00
2024-05-171450PUT0 0116.4TRUE00
2024-06-21650CALL0 072.86TRUE00
2024-06-21700CALL0 062.86TRUE00
2024-06-21750CALL0 053.63TRUE00
2024-06-21800CALL0 043.04TRUE00
2024-06-21850CALL0 035.62TRUE00
2024-06-2187.50CALL0 033.25TRUE00
2024-06-21900CALL0 029.28TRUE00
2024-06-2192.54CALL86 127.79TRUE0.410.11
2024-06-21953.03CALL2 126.15FALSE0.70.3
2024-06-2197.52.45CALL174 025.89FALSE2.450
2024-06-211000CALL0 025.21FALSE00
2024-06-211050.55CALL151 023.31FALSE0.550
2024-06-211100CALL0 028.2FALSE00
2024-06-211150CALL0 030.91FALSE00
2024-06-211200CALL0 042.77FALSE00
2024-06-211250CALL0 00FALSE00
2024-06-211300CALL0 00FALSE00
2024-06-211350CALL0 00FALSE00
2024-06-211400CALL0 00FALSE00
2024-06-21650PUT0 00FALSE00
2024-06-21700PUT0 00FALSE00
2024-06-21750PUT0 042.41FALSE00
2024-06-21800PUT0 039.72FALSE00
2024-06-21850PUT0 021.92FALSE00
2024-06-2187.50PUT0 520.03FALSE00
2024-06-21901.4PUT33 919.11FALSE-0.49-0.26
2024-06-2192.52.4PUT24 017.91FALSE2.40
2024-06-21953.2PUT1 116.18TRUE-0.85-0.21
2024-06-2197.54.7PUT2 114.95TRUE-1.11-0.19
2024-06-211006.5PUT1 012.34TRUE6.50
2024-06-211050PUT0 00TRUE00
2024-06-211100PUT0 041.69TRUE00
2024-06-211150PUT0 046.91TRUE00
2024-06-211200PUT0 054.61TRUE00
2024-06-211250PUT0 060.82TRUE00
2024-06-211300PUT0 066.66TRUE00
2024-06-211350PUT0 072.16TRUE00
2024-06-211400PUT0 059.51TRUE00
2024-07-1947.50CALL0 0109.83TRUE00
2024-07-19500CALL0 0102.83TRUE00
2024-07-19550CALL0 089.81TRUE00
2024-07-19600CALL0 078.63TRUE00
2024-07-19650CALL0 070.08TRUE00
2024-07-19700CALL0 059.32TRUE00
2024-07-19750CALL0 050.06TRUE00
2024-07-198022.6CALL0 041.74TRUE00
2024-07-198515.2CALL0 3135.47TRUE00
2024-07-1987.510.7CALL0 632.56TRUE00
2024-07-19906.9CALL0 3030.28TRUE00
2024-07-1992.55.6CALL1 4027.78TRUE1.10.24
2024-07-19954CALL5 58526.79FALSE0.80.25
2024-07-1997.52.41CALL0 32925.65FALSE00
2024-07-191001.8CALL45 26824.75FALSE0.30.2
2024-07-191051CALL169 68123.89FALSE0.350.54
2024-07-191100.35CALL0 108524.41FALSE00
2024-07-191150.2CALL0 73425.99FALSE00
2024-07-191200.15CALL189 38126.47FALSE0.150
2024-07-191250.1CALL0 55236.21FALSE00
2024-07-191300.16CALL0 480FALSE00
2024-07-191350CALL0 00FALSE00
2024-07-191400CALL0 00FALSE00
2024-07-191450CALL0 00FALSE00
2024-07-191500.05CALL0 50FALSE00
2024-07-1947.50PUT0 00FALSE00
2024-07-19500.15PUT0 1240FALSE00
2024-07-19550PUT0 00FALSE00
2024-07-19600PUT0 00FALSE00
2024-07-19650.1PUT0 10FALSE00
2024-07-19700.1PUT0 1000FALSE00
2024-07-19750.25PUT0 1330.69FALSE00
2024-07-19800.4PUT0 1622.29FALSE00
2024-07-19850.8PUT54 14819.93FALSE0.80
2024-07-1987.51.5PUT0 24918.43FALSE00
2024-07-19901.8PUT52 45417.02FALSE-0.25-0.12
2024-07-1992.52.5PUT81 62515.98FALSE2.50
2024-07-19953.5PUT69 84714.17TRUE-0.7-0.17
2024-07-1997.55.6PUT0 53713.01TRUE00
2024-07-191007.5PUT0 4099.46TRUE00
2024-07-1910510.55PUT0 1820TRUE00
2024-07-1911010.7PUT0 332.3TRUE00
2024-07-1911511.7PUT0 138.33TRUE00
2024-07-1912015.02PUT0 043.95TRUE00
2024-07-1912527PUT0 049.23TRUE00
2024-07-1913023.61PUT0 054.2TRUE00
2024-07-1913528.52PUT0 058.9TRUE00
2024-07-1914033.4PUT0 060.14TRUE00
2024-07-1914547.3PUT0 066.52TRUE00
2024-07-1915043.7PUT0 069.45TRUE00
2024-10-1847.50CALL0 092.75TRUE00
2024-10-18500CALL0 088.04TRUE00
2024-10-18550CALL0 079.59TRUE00
2024-10-18600CALL0 070.33TRUE00
2024-10-18650CALL0 062.75TRUE00
2024-10-18700CALL0 055.34TRUE00
2024-10-18750CALL0 046.87TRUE00
2024-10-188024.3CALL0 441.47TRUE00
2024-10-188515.3CALL0 139.54TRUE00
2024-10-1887.50CALL0 031.41TRUE00
2024-10-18908.9CALL13 4029.6TRUE0.90.11
2024-10-1892.57.3CALL2 2629.95TRUE7.30
2024-10-18955.6CALL2 728.38FALSE5.60
2024-10-1897.54.5CALL1 7327.06FALSE4.50
2024-10-181003.5CALL2 16225.96FALSE3.50
2024-10-181052.1CALL115 25224.49FALSE0.50.31
2024-10-181101.15CALL200 8822.91FALSE1.150
2024-10-181150.72CALL0 50423.44FALSE00
2024-10-181200CALL0 023.57FALSE00
2024-10-181250.25CALL0 1125.33FALSE00
2024-10-181300CALL0 028.93FALSE00
2024-10-181350CALL0 00FALSE00
2024-10-181400CALL0 00FALSE00
2024-10-181450CALL0 00FALSE00
2024-10-181500CALL0 00FALSE00
2024-10-1847.50PUT0 00FALSE00
2024-10-18500PUT0 00FALSE00
2024-10-18550PUT0 00FALSE00
2024-10-18600PUT0 00FALSE00
2024-10-18650PUT0 00FALSE00
2024-10-18700PUT0 031.95FALSE00
2024-10-18750.45PUT0 3222.29FALSE00
2024-10-18800.9PUT0 11519.46FALSE00
2024-10-18851.55PUT0 220016.87FALSE00
2024-10-1887.51.67PUT0 9115.43FALSE00
2024-10-18902.5PUT0 34214.41FALSE00
2024-10-1892.54.1PUT0 35712.7FALSE00
2024-10-18954.43PUT0 15011.56TRUE00
2024-10-1897.56.2PUT4 2898.84TRUE6.20
2024-10-181007PUT0 375.21TRUE00
2024-10-181059.6PUT0 20TRUE00
2024-10-1811010.6PUT0 00TRUE00
2024-10-181150PUT0 021.67TRUE00
2024-10-181200PUT0 026.99TRUE00
2024-10-181250PUT0 031.15TRUE00
2024-10-181300PUT0 035.1TRUE00
2024-10-181350PUT0 038.83TRUE00
2024-10-181400PUT0 030.8TRUE00
2024-10-181450PUT0 044.88TRUE00
2024-10-181500PUT0 048.07TRUE00
2025-01-1737.564.93CALL1 00TRUE00
2025-01-17400CALL0 00TRUE00
2025-01-1742.50CALL0 00TRUE00
2025-01-17450CALL0 00TRUE00
2025-01-1747.559.4CALL0 087.03TRUE00
2025-01-175052.6CALL0 1783.28TRUE00
2025-01-17550CALL0 075.36TRUE00
2025-01-176042.5CALL0 067.62TRUE00
2025-01-176538.1CALL0 860.3TRUE00
2025-01-1767.50CALL0 00TRUE00
2025-01-177031.4CALL0 054.49TRUE00
2025-01-1772.517.45CALL2 70TRUE00
2025-01-177531CALL0 147.26TRUE00
2025-01-1777.530.7CALL7 70TRUE00
2025-01-178022.75CALL0 1042.97TRUE00
2025-01-1782.50CALL0 00TRUE00
2025-01-178518.96CALL0 237.67TRUE00
2025-01-1787.511.9CALL0 1935.44TRUE00
2025-01-179011.1CALL0 28135.88TRUE00
2025-01-1792.58.45CALL0 6332.01TRUE00
2025-01-17957.9CALL0 8830.7FALSE00
2025-01-1797.56.3CALL4 11329.23FALSE6.30
2025-01-171006.81CALL0 29828.22FALSE00
2025-01-171053.4CALL50 60426.44FALSE3.40
2025-01-171102.15CALL2 62725.12FALSE0.450.26
2025-01-171151.35CALL18 40724.45FALSE1.350
2025-01-171200.8CALL150 50123FALSE0.120.18
2025-01-171250.4CALL0 42523.36FALSE00
2025-01-171300.4CALL0 47523.66FALSE00
2025-01-171350.65CALL0 23032.24FALSE00
2025-01-171400.6CALL0 9927.8FALSE00
2025-01-171450.25CALL0 770FALSE00
2025-01-171500.3CALL0 70FALSE00
2025-01-171550.28CALL0 10FALSE00
2025-01-171600.15CALL0 50FALSE00
2025-01-1737.50.2PUT1 2450FALSE00
2025-01-17400PUT0 00FALSE00
2025-01-1742.51PUT0 50FALSE00
2025-01-17450PUT0 00FALSE00
2025-01-1747.50.25PUT0 4900FALSE00
2025-01-17500.2PUT0 110FALSE00
2025-01-17550PUT0 00FALSE00
2025-01-17600.5PUT0 00FALSE00
2025-01-17650.75PUT0 51734.43FALSE00
2025-01-1767.50.9PUT1 320FALSE00
2025-01-17700.55PUT0 31424.64FALSE00
2025-01-1772.51.15PUT1 10FALSE00
2025-01-17750.75PUT0 19219.87FALSE00
2025-01-1777.51.2PUT2 2440FALSE00
2025-01-17801.11PUT0 18017.62FALSE00
2025-01-1782.52.35PUT1 2510FALSE00
2025-01-17851.9PUT0 66715.23FALSE00
2025-01-1787.52.65PUT5 11114.31FALSE-0.35-0.12
2025-01-17903.2PUT0 29912.82FALSE00
2025-01-1792.54PUT0 91311.67FALSE00
2025-01-17954.3PUT0 1309.91TRUE00
2025-01-1797.55.8PUT0 2177.62TRUE00
2025-01-171008PUT112 1855.5TRUE-0.85-0.1
2025-01-1710512.5PUT0 3240TRUE00
2025-01-1711014.1PUT0 20TRUE00
2025-01-1711519.5PUT0 00TRUE00
2025-01-1712018PUT0 016.18TRUE00
2025-01-1712522.7PUT0 021.18TRUE00
2025-01-1713028.3PUT0 025.35TRUE00
2025-01-171350PUT0 029.09TRUE00
2025-01-171400PUT0 00TRUE00
2025-01-171450PUT0 034.88TRUE00
2025-01-171500PUT0 037.07TRUE00
2025-01-171550PUT0 040.67TRUE00
2025-01-171600PUT0 042.58TRUE00
2026-01-1647.50CALL0 070.66TRUE00
2026-01-165054.8CALL0 068.64TRUE00
2026-01-16550CALL0 060.84TRUE00
2026-01-166048CALL0 055.57TRUE00
2026-01-16650CALL0 050.5TRUE00
2026-01-167032.1CALL0 2245.21TRUE00
2026-01-16750CALL0 044.62TRUE00
2026-01-168027.5CALL0 240.92TRUE00
2026-01-168518.62CALL0 2037.74TRUE00
2026-01-1687.517.9CALL0 5235.1TRUE00
2026-01-169016.5CALL0 1135.71TRUE00
2026-01-1692.50CALL0 034.53TRUE00
2026-01-169512.3CALL10 033.23FALSE12.30
2026-01-1697.517CALL0 633.5FALSE00
2026-01-161009CALL0 5931.46FALSE00
2026-01-161057.5CALL1 15129.34FALSE7.50
2026-01-161105.5CALL0 39928.23FALSE00
2026-01-161155.6CALL0 11229.75FALSE00
2026-01-161203.48CALL0 21527.7FALSE00
2026-01-161252.3CALL0 20024.58FALSE00
2026-01-161303CALL0 528.04FALSE00
2026-01-161350CALL0 028.83FALSE00
2026-01-161401.85CALL0 2730.38FALSE00
2026-01-161451.53CALL0 3529.79FALSE00
2026-01-161500.8CALL0 633.43FALSE00
2026-01-161550CALL0 034.17FALSE00
2026-01-161600CALL0 00FALSE00
2026-01-1647.50.8PUT0 240FALSE00
2026-01-16500PUT0 031.52FALSE00
2026-01-16550.7PUT0 00FALSE00
2026-01-16600PUT0 028.67FALSE00
2026-01-16650.95PUT0 524.49FALSE00
2026-01-16701.4PUT0 3522.98FALSE00
2026-01-16751.85PUT0 8417.78FALSE00
2026-01-16803PUT0 74215.52FALSE00
2026-01-16853.2PUT0 45513.03FALSE00
2026-01-1687.53.9PUT0 37311.66FALSE00
2026-01-16904.38PUT0 12212.92FALSE00
2026-01-1692.57PUT0 748.54FALSE00
2026-01-16957.1PUT0 1779.18TRUE00
2026-01-1697.59.3PUT1 1112TRUE9.30
2026-01-161007.5PUT0 310.45TRUE00
2026-01-1610513.4PUT1 2300TRUE13.40
2026-01-1611011.83PUT0 00TRUE00
2026-01-1611518.07PUT0 20TRUE00
2026-01-161200PUT0 00TRUE00
2026-01-1612524.7PUT0 00TRUE00
2026-01-1613026PUT0 00TRUE00
2026-01-161350PUT0 00TRUE00
2026-01-161400PUT0 00TRUE00
2026-01-161450PUT0 012.79TRUE00
2026-01-161500PUT0 020.24TRUE00
2026-01-161550PUT0 023.85TRUE00
2026-01-161600PUT0 026.71TRUE00

Latest NVS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST2$82.55
Jun 13, 2022 7:59 PM EST2$82.55
Jun 13, 2022 7:59 PM EST14$82.55
Jun 13, 2022 7:59 PM EST8$82.53
Jun 13, 2022 7:59 PM EST200$82.54

Novartis AG (NVS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920080559/0001104659-20-080559-index.htm
2019-11-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000089924319026793/0000899243-19-026793-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000089924319027115/0000899243-19-027115-index.htm
2020-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000089924320017188/0000899243-20-017188-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2019-03-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000143/0000925421-19-000143-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000179/0000925421-19-000179-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000256/0000925421-20-000256-index.htm
2019-12-05SC TO-TTender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000104746919006660/0001047469-19-006660-index.htm
2020-01-30F-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1114448/000104746920000609/0001047469-20-000609-index.htm
2020-02-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1114448/000104746920000795/0001047469-20-000795-index.htm
2020-02-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1114448/000104746920000837/0001047469-20-000837-index.htm
2020-02-14POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1114448/000104746920000872/0001047469-20-000872-index.htm
2019-05-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465919031228/0001104659-19-031228-index.htm
2019-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465919032920/0001104659-19-032920-index.htm
2019-05-31SDhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919032999/0001104659-19-032999-index.htm
2019-11-25SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919066818/0001104659-19-066818-index.htm
2019-11-25SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919067074/0001104659-19-067074-index.htm
2019-12-19SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919074076/0001104659-19-074076-index.htm
2019-12-23SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919075309/0001104659-19-075309-index.htm
2020-01-06SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465920001225/0001104659-20-001225-index.htm
2020-02-12FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920016892/0001104659-20-016892-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054421/0001104659-20-054421-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054428/0001104659-20-054428-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054430/0001104659-20-054430-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054435/0001104659-20-054435-index.htm
2020-06-01SDhttps://www.sec.gov/Archives/edgar/data/1114448/000110465920068035/0001104659-20-068035-index.htm
2020-06-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920076964/0001104659-20-076964-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920080559/0001104659-20-080559-index.htm
2020-07-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920082864/0001104659-20-082864-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920084106/0001104659-20-084106-index.htm
2020-08-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920095585/0001104659-20-095585-index.htm
2020-08-19SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920096920/0001104659-20-096920-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319001715/0001171843-19-001715-index.htm
2019-03-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319001911/0001171843-19-001911-index.htm
2019-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319002004/0001171843-19-002004-index.htm
2019-05-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003156/0001171843-19-003156-index.htm
2019-05-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003609/0001171843-19-003609-index.htm
2019-05-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003610/0001171843-19-003610-index.htm
2019-05-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003629/0001171843-19-003629-index.htm
2019-06-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003886/0001171843-19-003886-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319004272/0001171843-19-004272-index.htm
2019-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319004915/0001171843-19-004915-index.htm
2019-08-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319005727/0001171843-19-005727-index.htm
2019-09-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319005958/0001171843-19-005958-index.htm
2019-09-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006182/0001171843-19-006182-index.htm
2019-10-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006290/0001171843-19-006290-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006403/0001171843-19-006403-index.htm
2019-10-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006937/0001171843-19-006937-index.htm
2019-11-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007057/0001171843-19-007057-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007596/0001171843-19-007596-index.htm
2019-11-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007762/0001171843-19-007762-index.htm
2019-12-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007956/0001171843-19-007956-index.htm
2019-12-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319008118/0001171843-19-008118-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320000083/0001171843-20-000083-index.htm
2020-01-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320000619/0001171843-20-000619-index.htm
2020-02-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320001368/0001171843-20-001368-index.htm
2020-03-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320001424/0001171843-20-001424-index.htm
2020-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320001840/0001171843-20-001840-index.htm
2020-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320002076/0001171843-20-002076-index.htm
2020-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320002077/0001171843-20-002077-index.htm
2020-04-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320002294/0001171843-20-002294-index.htm
2020-05-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320003608/0001171843-20-003608-index.htm
2020-06-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320004387/0001171843-20-004387-index.htm
2020-06-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320004563/0001171843-20-004563-index.htm
2020-07-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320004689/0001171843-20-004689-index.htm
2020-08-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320005971/0001171843-20-005971-index.htm
2020-08-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320006020/0001171843-20-006020-index.htm
2020-09-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320006198/0001171843-20-006198-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320006593/0001171843-20-006593-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320007068/0001171843-20-007068-index.htm
2019-04-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036819000028/0001370368-19-000028-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036819000049/0001370368-19-000049-index.htm
2019-10-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036819000062/0001370368-19-000062-index.htm
2020-01-2920-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm
2020-01-29IRANNOTICENotice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Acthttps://www.sec.gov/Archives/edgar/data/1114448/000137036820000005/0001370368-20-000005-index.htm
2020-01-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000007/0001370368-20-000007-index.htm
2020-04-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000061/0001370368-20-000061-index.htm
2020-07-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000069/0001370368-20-000069-index.htm
2020-10-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000086/0001370368-20-000086-index.htm

Novartis AG (NVS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Novartis AG (NVS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: < 1%
Institutional Ownership: 1008%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-30Bioventures Ltd NovartisInsiderBuy125,000.0017.002,125,000.001,181,258.00https://www.sec.gov/Archives/edgar/data/1114448/000110465920080559/0001104659-20-080559-index.htm
2019-05-28Bioventures Ltd Novartis10% Share HolderBuy168,630.0014.002,360,820.001,769,641.00https://www.sec.gov/Archives/edgar/data/1114448/000110465919032920/0001104659-19-032920-index.htm
2019-04-01Bioventures Ltd Novartis10% Share HolderSell20,610.001.9039,159.002,079,394.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000143/0000925421-19-000143-index.htm
2019-03-29Bioventures Ltd Novartis10% Share HolderSell106,540.001.85197,099.002,100,004.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000143/0000925421-19-000143-index.htm
2019-03-15Bioventures Ltd Novartis10% Share HolderSell43,800.001.9284,096.002,206,544.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2019-03-14Bioventures Ltd Novartis10% Share HolderSell13,800.001.8825,944.002,250,344.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2019-03-13Bioventures Ltd Novartis10% Share HolderSell132,738.002.12281,404.562,264,144.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2020-06-19Bioventures Ltd NovartisInsiderSell1,001,312.008.258,260,824.002,467,961.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000256/0000925421-20-000256-index.htm
2020-06-18Bioventures Ltd NovartisInsiderSell900.009.048,136.003,469,273.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000256/0000925421-20-000256-index.htm
2020-06-17Bioventures Ltd Novartis10% Share HolderSell4,622.009.2742,845.943,470,173.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-16Bioventures Ltd Novartis10% Share HolderSell8,600.009.3079,980.003,474,795.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-15Bioventures Ltd Novartis10% Share HolderSell6,164.009.0555,784.203,483,395.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-12Bioventures Ltd Novartis10% Share HolderSell1,500.009.1913,785.003,489,559.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-11Bioventures Ltd Novartis10% Share HolderSell7,200.009.2166,312.003,491,059.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-10Bioventures Ltd Novartis10% Share HolderSell8,532.009.4680,712.723,498,259.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-09Bioventures Ltd Novartis10% Share HolderSell7,000.009.3865,660.003,506,791.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-08Bioventures Ltd Novartis10% Share HolderSell5,659.009.6654,665.943,513,791.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-05Bioventures Ltd Novartis10% Share HolderSell8,652.009.6683,578.323,519,450.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-04Bioventures Ltd Novartis10% Share HolderSell4,088.009.5539,040.403,528,102.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2020-06-03Bioventures Ltd Novartis10% Share HolderSell5,208.009.7850,934.243,532,190.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2020-06-02Bioventures Ltd Novartis10% Share HolderSell5,669.009.6854,875.923,537,398.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2019-11-12Bioventures Ltd Novartis10% Share HolderBuy250,000.0012.003,000,000.003,543,067.00https://www.sec.gov/Archives/edgar/data/1114448/000089924319027115/0000899243-19-027115-index.htm
2019-04-26Bioventures Ltd Novartis10% Share HolderSell138,704.001.03142,865.124,049,804.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000179/0000925421-19-000179-index.htm
2019-04-25Bioventures Ltd Novartis10% Share HolderSell563,096.001.03579,988.884,188,508.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000179/0000925421-19-000179-index.htm
2019-04-24Bioventures Ltd Novartis10% Share HolderSell16,403.001.0316,895.094,751,604.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-23Bioventures Ltd Novartis10% Share HolderSell27,554.001.0328,380.624,768,007.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-22Bioventures Ltd Novartis10% Share HolderSell7,100.000.976,887.004,795,561.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-15Bioventures Ltd Novartis10% Share HolderSell28,794.000.9928,506.064,802,661.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-12Bioventures Ltd Novartis10% Share HolderSell30,908.001.0432,144.324,831,455.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-11Bioventures Ltd Novartis10% Share HolderSell57,438.001.0862,033.044,862,363.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-10Bioventures Ltd Novartis10% Share HolderSell140,230.001.09152,850.704,919,801.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-09Bioventures Ltd Novartis10% Share HolderSell32,991.001.0133,320.915,060,031.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-08Bioventures Ltd Novartis10% Share HolderSell27,525.001.0228,075.505,093,022.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-05Bioventures Ltd Novartis10% Share HolderSell24,661.001.0225,154.225,120,547.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-04Bioventures Ltd Novartis10% Share HolderSell47,900.001.0148,379.005,145,208.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-03Bioventures Ltd Novartis10% Share HolderSell58,033.000.9655,711.685,193,108.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-02Bioventures Ltd Novartis10% Share HolderSell51,754.000.9750,201.385,251,141.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-04-01Bioventures Ltd Novartis10% Share HolderSell116,909.000.95111,063.555,302,895.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-03-29Bioventures Ltd Novartis10% Share HolderSell63,100.000.9157,421.005,419,804.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-03-28Bioventures Ltd Novartis10% Share HolderSell88,835.000.9483,504.905,482,904.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm
2019-03-27Bioventures Ltd Novartis10% Share HolderSell50,749.000.9950,241.515,571,739.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm
2019-03-26Bioventures Ltd Novartis10% Share HolderSell177,762.001.01179,539.625,622,488.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm